MarketFriction

Astec Lifesciences Ltd

NSE ASTEC · BSE 533138 · Pesticides & Agrochemicals
₹708.60 -1.96%
NSE close2026-10-01
52 week range513.40 - 941.75
Market cap₹1,552 Cr.
ASM short-term Price band 20% Delivery 34.0%

Price

Drag to pan, scroll or pinch to zoom. Ruler (or Shift + drag) measures a move.Dashed lines: 52 week high and low. Prices adjusted for splits and bonuses.

Financials

Consolidated, Rs crore
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales11151154699994120917412515984
Expenses114691411161181001141028012114984
Operating Profit-3-1813-46-20-66-11-749-1
OPM %-3.1%-36%8%-67%-20%-6%4.6%-12%-9%3.2%6%-0.8%
Other Income112122111-131
Interest667791010118788
Depreciation99991111121110111211
Profit before tax-18-32-1-62-39-25-16-33-24-16-8-19
Tax %-24%-24%4%-36%0%61%3%0%0%0%-2%-0%
Net Profit-13-24-1-40-39-40-16-33-24-16-8-19
EPS in Rs-6.00-10.86-0.43-17.73-17.21-18.03-7.18-14.75-10.96-7.05-3.48-8.40
Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales233299368431523555677628458381448441
Expenses201236299354437443522551464448453435
Operating Profit326369768511215477-6-66-46
OPM %14%21%19%18%16%20%23%12%-1.3%-17%-1.0%1.3%
Other Income4-8121112810136633
Interest1312111213592125373531
Depreciation101415192326343436444544
Profit before tax12295656618912135-62-141-81-67
Tax %59%33%37%36%23%27%26%27%-24%-4%-0%
Net Profit519353648659026-47-135-81-67
EPS in Rs2.248.5715.6516.0321.2129.0440.1211.41-20.95-60.16-36.32-29.89
Dividend Payout %0%15%8%8%6%5%3%12%0%0%0%
10 Years5 Years3 YearsTTM1 YearLast Year
Compounded Sales Growth7%-4%-11%9%
Compounded Profit Growth%%%50%
Stock Price CAGR5%-11%-19%-14%
Return on Equity2%-8%-26%-25%
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital191920202020202020202022
Reserves11699119150183227290377400350215368
Borrowings9312712712517699187279341494555449
Other Liabilities13385691198322618122121911292102
Total Liabilities362330334413461572678897979975881942
Fixed Assets13395103115167194213340318386499459
CWIP12208421924116231271652120
Investments000000000000
Other Assets216215223256275354349534534424361463
Total Assets362330334413461572678897979975881942
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity7-13196515168-8247510-8-81
Cash from Investing Activity-19-17-18-49-52-74-73-104-113-135-15-4
Cash from Financing Activity1231-1-1837-958180381252494
Net Cash Flow-021-3-0000-0009
Free Cash Flow-13-39-115-37123-111-80-42-125-24-86
CFO/OP19%-24%41%116%41%219%13%34%104%-211%20%1,796%
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days14212613512210311212314890135141202
Inventory Days147177133122121131113176268224196169
Days Payable17916911615583218137179161102100107
Cash Conversion Cycle1091341528914225100145197256237263
Working Capital Days19-281-8-28412-17-1-26-56
ROCE %20%12%20%22%20%20%22%22%8%-4%-13%-5%
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters66.75%66.75%66.75%66.75%66.74%66.74%70.87%70.87%72.42%71.97%71.97%71.97%
FIIs1.33%1.28%1.25%1.03%0.53%1.20%0.25%0.02%0.00%0.04%0.03%0.01%
DIIs10.16%9.74%7.88%3.37%4.50%5.40%4.34%4.26%4.01%3.17%3.33%3.33%
Public21.74%22.22%24.12%28.85%28.20%26.64%24.53%24.84%23.57%24.82%24.67%24.69%
No. of Shareholders18,72219,24419,84819,95519,72719,05718,68918,54918,27622,29321,04119,889

Fundamentals

Market Cap₹ 1,552 Cr.
Current Price₹ 696
Book Value₹ 175
ROCE-5.44 %
ROE-25.2 %
Dividend Yield0.00 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)9%
Compounded Profit Growth (TTM)50%
Consolidated figures.
Valuation
Market capRs 1,579 Cr
Enterprise valueRs 2,016 Cr
Price to book4.04x
Price to sales3.58x
EV / EBITDA224.20x
EV / sales4.57x
Earnings yield-4.22%
P/B, 3-year average4.77x
P/E, 5-year average71.71x
P/B, 5-year average5.87x
Profitability
Operating margin (excl. other income)-1.00%
Operating margin (incl. other income)-0.35%
EBITDA margin2.04%
Pre-tax margin-15.14%
Net profit margin-15.12%
Net margin, latest quarter-22.40%
ROE-25.88%
ROCE-5.71%
ROA-8.88%
ROE, 3-year average-27.47%
ROCE, 3-year average-7.61%
ROA, 3-year average-9.40%
ROE, 5-year average-10.13%
ROCE, 5-year average1.43%
ROA, 5-year average-2.81%
ROIC (approx.)-4.29%
Tax rate0.15%
Other income / net worth0.74%
Growth
Sales growth (latest year)17.53%
Sales CAGR, 3 years-10.65%
Sales CAGR, 5 years-4.18%
Sales growth QoQ-47.32%
Sales growth YoY (latest quarter)-8.26%
Per share
EPS (TTM)Rs -29.89
EPS (latest year)Rs -36.32
EPS (latest quarter)Rs -8.40
EPS, 3-year averageRs -42.99
EPS, 5-year averageRs -14.01
Book value per shareRs 175.30
Sales per shareRs 197.74
Cash flow per shareRs -36.22
Free cash flow per shareRs -38.60
Dividend per share, 5-year averageRs 1.50
Dividends
Dividend payout, 5-year average7.39%
Efficiency
Asset turnover0.48x
Fixed asset turnover0.98x
Inventory turnover2.59x
Inventory days141 days
Debtor days202 days
Debtors turnover1.81x
Creditor days107 days
Cash conversion cycle263 days
Working capital days-56 days
Leverage
Total debtRs 449 Cr
Cash and bankRs 12 Cr
Net debtRs 437 Cr
Debt to equity1.15x
Net debt / EBITDA48.57x
Interest coverage-1.14x
Current ratio (filing 2026-03-31)0.89x
Quick ratio (filing 2026-03-31)0.61x
Trade payables (filing 2026-03-31)Rs 88 Cr
Owners' fund to total sources41.46%
Debt to assets47.66%
Cash flow
Cash from Operating Activity (latest year)Rs -81 Cr
Cash from Investing Activity (latest year)Rs -4 Cr
Cash from Financing Activity (latest year)Rs 94 Cr
Net Cash Flow (latest year)Rs 9 Cr
Free cash flow (latest year)Rs -86 Cr
FCFE (approx.: FCF + change in debt)Rs -192 Cr
Statement figures
Net sales (TTM)Rs 441 Cr
Net sales (latest year)Rs 448 Cr
Sales (latest quarter)Rs 84 Cr
Operating profit excl. other income (latest year)Rs -4 Cr
Operating profit (latest quarter)Rs -1 Cr
Other income (TTM)Rs 3 Cr
EBITDA (TTM)Rs 9 Cr
PBDT (TTM)Rs -22 Cr
Profit before tax (TTM)Rs -67 Cr
Tax (latest year)Rs -0 Cr
Net profit (TTM)Rs -67 Cr
Net profit (latest year)Rs -81 Cr
Net profit (latest quarter)Rs -19 Cr
Depreciation (TTM)Rs 44 Cr
Depreciation (latest quarter)Rs 11 Cr
Interest (TTM)Rs 31 Cr
Cost of goods sold (latest year)Rs 358 Cr
Total expenditure (latest year)Rs 453 Cr
Total income (latest year)Rs 451 Cr
Share capitalRs 22 Cr
ReservesRs 368 Cr
Shareholders' fundsRs 391 Cr
Total assetsRs 942 Cr
Net blockRs 459 Cr
Capital work in progressRs 20 Cr
InvestmentsRs 0 Cr
ReceivablesRs 248 Cr
InventoryRs 138 Cr
Other liabilitiesRs 102 Cr
Shares outstanding (crore)2.23
Ownership
Promoter holding71.97% (+1.10 in a year)
Computed by MarketFriction from the consolidated statements. Returns use average balances.
P/B 4.04 is at the 3th percentile (median 7.59).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
PeriodASTECNifty 50Difference
1 week-2.8%-2.8% +0.0 pts
1 month+26.0%-6.8% +32.8 pts
3 months-0.2%-7.6% +7.4 pts
6 months+31.1%+0.4% +30.7 pts
1 year-14.5%-9.9% -4.6 pts
2 years-41.1%-13.6% -27.5 pts
3 years-46.5%+14.2% -60.6 pts
5 years-44.9%+27.9% -72.8 pts
4 mutual fund schemes hold about ₹39 Cr. Over three months 0 bought more and 4 sold (share counts, price move removed).
FundWeightEst. Cr3m shares
Nippon India Small Cap Fund0.04%30 -25%
ICICI Pru Commodities Fund0.17%7 -28%
ICICI Pru Mid Cap Fund0.01%1 -25%
ICICI Pru Mid Cap Fund0.01%1 -25%

Red flags

F-score 6 of 8
explainReceivables outrunning sales Receivables grew 68% vs sales +18% in 2026
lookRepeated losses Net loss in each of the last two years
lookOn NSE surveillance On NSE surveillance: ASM short-term
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.

Latest quarter

Jun 2026
Sales ₹84 Cr -7.7% vs Jun 2025. Net loss ₹19 Cr.

Activity

Compare
CompanyMcap (Cr)P/EROCE
UPL Ltd45,40223.010.1 %
P I Industries Ltd34,72532.215.0 %
Sumitomo Chemical India Ltd21,52137.723.5 %
Bayer CropScience Ltd16,19122.129.1 %
Sharda Cropchem Ltd6,50910.430.2 %
Dhanuka Agritech Ltd4,14815.523.8 %
Rallis India Ltd3,88217.014.1 %
Bhagiradha Chemicals & Industries Ltd3,1281144.53 %
NACL Industries Ltd3,1011208.13 %
GSP Crop Science Ltd2,19821.018.9 %
Insecticides India Ltd1,70613.615.8 %
Bharat Rasayan Ltd1,67312.016.1 %
India Pesticides Ltd1,53314.216.6 %
Meghmani Organics Ltd1,45822.76.71 %
Punjab Chemicals & Crop Protection Ltd1,28319.218.6 %
No bulk or block deals on record.
Ex-dateActionFactor
2025-07-04Rights 1:7 @ Premium Rs 880/-
2024-07-23Annual General Meeting
2023-07-21Annual General Meeting/Dividend - Rs 1.50 Per Share
2022-07-19Annual General Meeting/Dividend - Rs 1.50 Per Share
2021-07-22 Annual General Meeting/Dividend - Rs 1.50 Per Share
2020-07-16 Annual General Meeting/Dividend - Rs 1.50 Per Share
2019-07-18 Annual General Meeting/ Dividend - Rs 1.50 Per Share
2018-07-19 Annual General Meeting/Dividend- Rs 1.50 Per Share
2017-07-17 Annual General Meeting/Dividend - Rs 1.50 Per Share
2016-07-20 Annual General Meeting
2015-09-15 Annual General Meeting/ Dividend - Rs 1.25/- Per Share
2014-09-15Annual General Meeting / Dividend - Re 1/- Per Share
2013-09-02Annual General Meeting / Dividend Re 0.75/- Per Share
2012-09-13Annual General Meeting/Dividend Re 0.50 Per Share
2011-09-15Annual General Meeting And Dividend Re.0.50 Per Share
2010-08-12Annual General Meeting And Dividend Re.1/- Per Share
DateTypeWhat it says
2026-10-01Volume querySignificant increase in volume has been observed in Astec LifeSciences Limited. The Exchange, in order to ensure that investors have latest relevant i...
2026-09-30Volume querySignificant increase in volume has been observed in Astec LifeSciences Limited. The Exchange, in order to ensure that investors have latest relevant i...
2026-09-18Volume querySignificant increase in volume has been observed in Astec LifeSciences Limited. The Exchange, in order to ensure that investors have latest relevant i...
2026-09-17Volume querySignificant increase in volume has been observed in Astec LifeSciences Limited. The Exchange, in order to ensure that investors have latest relevant i...
2026-09-11Price movementSignificant movement in price has been observed in Astec LifeSciences Limited. The Exchange, in order to ensure that investors have latest relevant in...
2026-09-10Price movementSignificant movement in price has been observed in Astec LifeSciences Limited. The Exchange, in order to ensure that investors have latest relevant in...
2026-09-09Volume querySignificant increase in volume has been observed in Astec LifeSciences Limited. The Exchange, in order to ensure that investors have latest relevant i...
2026-09-08Volume querySignificant increase in volume has been observed in Astec LifeSciences Limited. The Exchange, in order to ensure that investors have latest relevant i...
2026-07-31UpdatesAdoption of Annual Report 2025-26 by the Shareholders at the AGM held on 31st July, 2026..
2026-07-31Shareholder meetingProceedings of Annual General Meeting held on July 31, 2026. Further, the company has submitted the Exchange a copy of Srutinizers report along with v...
2026-07-31General UpdatesGeneral Updates
2026-07-31Press ReleaseA press release dated July 31, 2026, titled "ASTEC: Astec LifeSciences Limited has informed the Exchange regarding a press release dated July 31, 2026...
2026-07-31Board meeting outcomeOutcome of Board Meeting held on July 31, 2026.
2026-07-31Board meeting outcomeOUTCOME OF BOARD MEETING
2026-07-08UpdatesClosure of Register of Members and Share Transfer Books..
2026-07-08UpdatesAnnual General Meeting and Annual Report 2025-26.
2026-07-08Shareholder meetingNotice of Annual General Meeting to be held on July 31, 2026 and Annual Report 2025-26.
2026-07-04Director changeChange in Director(s) of the company.
2026-07-04Shareholder meetingProceedings of Postal Ballot. Further, the company has submitted the Exchange a copy of Srutinizers report along with voting results.
2026-07-04UpdatesScrutinizers report.
2026-07-04General UpdatesPostal ballot.
2026-06-22Disclosure under SEBI TakeovGodrej Agrovet Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substa...
2026-06-19Disclosure under SEBI TakeovAshok V. Hiremath has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial...
2026-06-05ResignationResignation of Director/KMP/SMP
2026-06-05ResignationResignation of Director/KMP/SMP
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
EPS in the scrip is zero (4 trailing quarters)Loss makingShort Term Additional Surveillance Measure (Short Term ASM): stage 1
Data: NSE and BSE daily reports, company filings. Numbers only, not investment advice, not a SEBI-registered research service.Updated 2026-10-03